K&B Partners

HepQuant is a Denver-based company specializing in non-invasive, blood-based quantitative tests designed to assess liver health and aid healthcare providers in managing patients with liver disease. Their innovative HepQuant DuO test delivers a Disease Severity Index (DSI), enabling clinicians to make informed decisions about patient care, treatment efficacy, and risk assessment for advanced liver conditions. The company addresses the critical issues surrounding liver disease, which affects an estimated 30 to 40 percent of Americans, by providing tools that empower healthcare professionals to monitor disease progression and treatment responses effectively. HepQuant is committed to advancing liver health management through continuous innovation and participation in clinical trials, ensuring a robust impact on patient outcomes. Generated from the website

Hepquant, LLC, based in Greenwood Village, CO, is a pioneering company dedicated to improving the lives of individuals with liver diseases through innovative liver health products and services. Their Hepquant Duo test is a first-of-its-kind non-invasive quantitative liver function test that provides valuable insights into liver cell function and portal systemic shunting, aiding healthcare providers in managing patients more effectively. By developing non-invasive quantitative tests that directly measure liver health, Hepquant products enable healthcare providers to identify individuals at risk for developing chronic liver disease and to monitor treatment response or disease progression. With a focus on precision and impact, Hepquant is at the forefront of advancing liver health assessment and patient management in the field of liver disease. Generated from the website